Capsules complement

A common characteristic of most CNS bacterial pathogens (e.g., H. influenzae, Escherichia coli, and N. meningitidis) is the presence of an extensive polysaccharide capsule that is resistant to neutrophil phagocytosis and complement opsonization. 

The MG-2 Futura series of machines can be fitted with different numbers of dosators to give outputs ranging from 6000 to 96,000 capsules per hour. Because turret and annular powder bed dimensions would remain the same, few problems should be expected when scaling-up within this range on this machine. However, it is important to recognize that since the distance between dosators will increase when fewer than the full complement... 

The neuA (ORF 25) and neuB (ORF 24) gene products were functionally characterized by complementation of E. coli K1 mutants EV5 and EV24 that are defective in K1 polysialic acid capsule biosynthesis. The EV5 mutant was complemented to wild-type capsule production by introduction of neuA, and the EV24 mutation complemented by the neuB gene. 

Pluschke, G., Mayden, J., Achtman, M., Levine, R.P. Role of the capsule and the O-antigen in resistance of 018 K1 Escherichia coli to complement-mediated killing. J Bacteriol 42 (1983a) 907-913. 

Although it has, to date, not been possible to identify any common structural feature among all the polysaccharide capsules of bacteria associated with the most pathogenic human disease, there is one common feature in many of them. The capsular polysaccharide of type III group B Streptococcus has terminal sialic acid residues in its structure,62,63 as do the groups B and C N. meningitidis and K1 E. coli.3 -34 The ability of terminal sialic acid residues to inhibit the activation of complement by way of the alternative pathway has been well docu-... 

As with bacteria, fungal virulence factors can be divided into two main categories virulence fectors that facilitate infection and virulence factors that affect the host. Virulence factors that promote adherence to host cells and fecilitate fungal invasion include capsule production to inhibit phagocytosis and cytokines to depress the host immune system. Multiple virulence fectors target the host, such as cell wall polysaccharides that activate the complement cascade and provoke an inflammatory reaction or the secretion of cytokines and mycotoxins that directly damage host tissues. 

Uropathogenic E. coli cause 90% of the urinary tract infections. The bacteria colonize from the feces or perineal region and ascend the urinary tract to the bladder. With the aid of specific adhesins (pyelonephritis-associated pili) they are able to colonize the bladder. Another factor involved in the pathogenicity of the uropathogenic strains of E. coli is their resistance to complement-dependent bactericidal effect of serum. This phenomenon is associated with the presence of a capsule, which decrease the ability of antibodies and/or complement to bind to the bacterial surface, which in turn prevents the phagocytes from recognizing and engulfing the bacterial cells. 

S-SNEDDS complement the liquid SNEDDS and overcome the limitations that include poor stability and portability, plausible interactions of the formulation component with the capsule shell, and evaporation of the cosolvent leading to precipitation of the drug associated with the liquid SNEDDS. Reduction in the volume of administration, due to the solid state of S-SNEDDS, enhances precise dosing. Various techniques, such as adsorption on the inert carriers, spray drying, extrusion—spheronization, and melt granulation, have been explored for the formulation of S-SNEDDS (Tan et al., 2013). S-SNEDDS utilized for enhancing the oral bioavaUability of drug candidates are listed in Table 4.4. 

In 900MWe units, the capsules are irradiated along the outer surface of the thermal shield assembly. In 1300 and 1450 MWe units, the capsules are directly attached to the core barrel. In the case of Chooz-A, the thermal shield assembly was removed in 1970 and the surveillance capsules were then located under the core. The capsules are equipped with neutron dosimeters and thermal monitors, with some variations according to the reactor series. In all cases, activation dosimeters of nickel, copper and cobalt, as well as fissile dosimeters of uranium-238 and neptunium-237 are used. This instrumentation is complemented by iron and cadmium-shielded cobalt dosimeters in most cases and, in the most recent plants, also by niobium dosimeters. Each capsule contains temperature detectors based on eutectic alloys with melting points generally of 304 and 310 °C. 

Iwata H, Morikawa N, Fujii T, Takagi T, Samejima T, Ikada Y (1995) Does immunoisolation need to prevent the passage of antibodies and complement Tranplant Proc 27(6) 3224-3226 Kang J, Erdodi G, Kennedy JP (2007) Third-generation amphiphilic conetworks. III. Permeabilities and mechanical properties. J Polym Sci A Polym Chem 45(18) 4276 283 La Flamme KE, Mor G, Gong D, La Tempa T, Fusaro VA, Grimes CA, Desai TA (2005)Nanoporous alumina capsules for cellular macroencapsulation transport and biocompatibility. Diabetes Technol Ther 7(5) 684-694... 

---